HUMA · Humana Inc.
392.00
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro47.11B
PE
26.00
EV/EBITDA
N/A
DIV Yield
1.4%
Payout Ratio
36%
MQV Rating
5Very Weak
As at 13/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Near 52 Week Low
Key Fundamentals
EPS 3 yr Growth
-55.60%
EBITDA Margin
0.00%
Operating Cashflow
€921m
Free Cash Flow Return
3.20%
ROIC
4.10%
Interest Coverage
0.00
Quick Ratio
0.00
Performance
52 weeks range
Low 344 - 360
Trade Value (12mth)
US$1.00
1 week
0%
1 month
0%
YTD
0%
1 year
0%
All time high
360.00
Additional Data
Shares Outstanding (Fully Diluted)
121m
HALO Sector
Other Finance
Next Company Report Date
N/A
Next Ex Dividend Date
30-Oct-26
Next Dividend Pay Date
27-Nov-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| OrbiMed Advisors Private Equity | Subsidiary |
| Joseph C Ventura | Individual |
| David E. Dintenfass | Individual |
| Frank A. D'Amelio | Individual |
| Kurt J. Hilzinger | Individual |
